We have detected that you are using an Ad Blocker. PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Welcome to PracticeUpdate! We hope you are enjoying access to a selection of our top-read and most recent articles. Please register today for a free account and gain full access to all of our expert-selected content.
You can find your saved items on your dashboard, in the "saved" tab.
You've recommended your first item
Your recommendations help us improve our content suggestions for you and other PracticeUpdate members.
You've subscribed to your first topic alert
What does that mean?
Each day, we'll check to see if new items have been published to the topics you're subscribed to, and we'll send you one email with all of the new items from that day.
We'll keep all topic alert notifications available on your dashboard for 30 days, to make sure you don't miss anything.
Lastly, whenever you have unread items in the topics you've subscribed to, the "Alerts" icon will light up in the main menu. Just click on the bell to see your five most-recent, unread notifications.
In this study, the authors compared the incidence of telogen effluvium (TE) at eight New York City safety-net hospitals prior to the COVID-19 pandemic and during the pandemic. There was a threefold increase in TE diagnoses during the first 6 months of the pandemic compared with the preceding 6 months. Of the pandemic cases, 10 patients were positive for COVID-19 and 98 were negative or untested. The number of white patients diagnosed with TE pre-pandemic and during the pandemic was similar, but the number of cases of TE greatly increased in Hispanic individuals and other non-white individuals. There were few cases of TE in black individuals both pre-pandemic and during the pandemic.
The number of TE cases rose sharply during the COVID-19 pandemic. Increased diagnosis in Hispanic and non-white patients accounted for the majority of this increase.
Since the arrival of COVID-19, cases of telogen effluvium (TE) have substantially increased.1 In this study, we assess the influence of race, ethnicity and comorbidities on the incidence of this disorder during the pandemic.